Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

March 7, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Role of the lncRNA complex HCP5 in glioma treatment

Nitrogen dioxide reduction leads to an increase in crop yield

Olfactory Implants on the rise to fix the dysfunctional system

Role of the lncRNA complex HCP5 in glioma treatment
  • BiotechToday
  • World

Role of the lncRNA complex HCP5 in glioma treatment

bioxone July 7, 2022July 7, 2022

Harini Balasubramanian, Anna University, Chennai

The investigation of non-coding regions of the DNA, especially miRNA and long non-coding RNA (lncRNA), and their role in various disease phenotypes, has drawn the attention of scientists in recent years. Gliomas are neoplasias usually found in the brain, a stage IV progression of which leads to glioblastoma (GBM). GBM is highly fatal with a median survival rate of merely 15 months. It is therefore essential that for a better understanding of the disease progression, more studies need to be conducted.

LncRNAs have been found to interact with miRNAs — short non-coding RNAs with up to 22 nucleotides. miRNAs regulate most of the post-transcriptional gene expression in a cell – to either stimulate malignancy or tumor suppression. lncRNA HLA complex P5 (HCP5) has been discovered to have carcinogenic properties by promoting cell proliferation, migration, and angiogenesis in follicular thyroid carcinoma cells. miR-205 is a miRNA of interest in this study, given its tumor-suppressive properties in gliomas, as established in previous studies.

So, this study investigated the previously unexplored role of HCP5 in glioma progression. Also, it further investigated the interaction of HCP5 with miR-205 and their combined molecular mechanisms along the VEGF-A axis (an essential factor in vascularizing tumors) in affecting glioma progression. 

Methodology:

  1. RNA Sequencing, Data processing, Analysis
  2. The culture of a patient’s primary GBM cell line (U251), Normal Human Astrocyte (NHA), and tumor tissue were obtained from patient.
  3. Cell transfection: siRNA against HCP5, miR-205 mimics, and negative control mimics were synthesized. Vectors for shRNA targeting HCP5 and the human VEGF-A gene were transfected into primary GBM cells.
  4. Cell viability assay, scratch wound healing assay for cell migration and invasiveness, and cell proliferation assays were conducted.
  5. In vivo xenograft study in mice was performed by injecting them subcutaneously with U251 cells post-transfection.
  6. qRT-PCR was performed to quantify expression levels of HCP5, miR-205, and VEGF-A.
  7. Western Blot analysis was done to primarily quantify VEGF-A protein concentration.

Outcome & Inference:

In different types of cancers, HCP5 was found to be significantly more upregulated compared to healthy control samples. The RNA sequencing data derived from TCGA projects also revealed the prognosis and thereby, that the survival rate had a negative correlation with expression levels 0f HCP5. For gliomas, in particular, the results showed that overexpression of HCP5 may be implicated in glioma progression.

Conversely, it also proved that in cells with siRNA transfection and subsequent HCP5 knockdown, its downregulation prominently mitigated cell viability and migration. In vivo studies also showed slowed tumor growth in mice injected with HCP5-silenced GBM cells.

In addition, HCP5’s interaction with miR-205 downregulated (relative to NHA cell line) the former’s expression in GBM cell lines. It was also found that miR-205 expression has an inverse relationship with HCP5, as the latter-silenced GBM cells had elevated levels of miR-205.

Regarding the feedback loop modulating GBM progression, the researchers determined that HCP5 downregulation was strongly associated with the downregulation of VEGF-A, both of which strikingly decreased upon upregulation of miR-205. So, they ascertained that by targeting miR-205, HCP5 modulated the expression of VEGF-A.

The results of this study, therefore, provide potential theragnostic targets for glioma treatment and specific drug development.

Reference:

Cheng, R., Ji, L., Su, H., Wang, L., Jia, D., Yao, X. and Ji, H. Silencing of Long Noncoding RNA HLA Complex P5 (HCP5) Suppresses Glioma Progression through the HCP5-miR-205-Vascular Endothelial Growth Factor A Feedback Loop. BioMed Research International, 2022. https://pubmed.ncbi.nlm.nih.gov/35769676/

Also read: Nitrogen dioxide reduction leads to an increase in crop yield

  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged feedback mechanism Glioma glioma treatment HCP5 lncRNA lncRNA complex miRNA transcriptomics Prognosis vascularization

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Olfactory Implants on the rise to fix the dysfunctional system

BioTech Today July 9, 2022

Jaladhi Shah, Dr D. Y. Patil Biotechnology and Bioinformatics Institute, Pune The aftermath of COVID-19 on the olfactory system: Following the multiple waves of COVID-19 that the world has witnessed, a lot of people, infected or uninfected have been subject to making changes in their lives. One such lifestyle adjustment that a lot of COVID-19 […]

Olfactory Implants

Related Post

  • BiotechToday
  • World

Genetically modified mosquitoes to control the Zika virus?

bioxone February 4, 2021February 4, 2021

Prama Ghosh, Amity University Kolkata The Zika virus epidemic was a public health emergency, causing birth defects for pregnant women in addition to neurological problems. The virus gets transmitted to humans from female mosquito bites. Researchers have tried several techniques to eliminate the spread of the virus, one of which is the use of genetically […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

DRH: DNA repair hotspots in neurons and Age-related disorders

bioxone April 23, 2021April 23, 2021

Sayak Banerjee, Amity University Kolkata Many people have a wrong conception that since DNA damage can occur any time at any genomic site of a neuron, DNA repairs take place throughout the genome arbitrarily. Salk scientists have proved this view to be invalid saying that genomic sites are benefitted. Genomic sites are also known as […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Genetically modified mouse models to fight COVID-19

bioxone October 30, 2020October 29, 2020

Soumya Sarathi Ganguly, Indian Institute of Technology, Kharagpur There is a dire need for animal models in which vaccines against coronavirus disease or therapeutics can be tested. Besides, to understand the molecular mechanism of SARS-CoV-2 infection and pathogenesis. Several animal models, like cats, ferrets, hamsters, and monkeys are susceptible, but there are a few challenges […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy